Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Zentalis Pharmaceuticals, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Pharmaceutical Preparations
No intraday reading yet this session.
114 institutional managers report a position in Zentalis Pharmaceuticals, Inc. worth $232.7M between them, filed on form 13F for the quarter ending 2026-06-30. 22 of them hold 80% of it, the largest being Squadron Capital Management LLC at 8.60%.
89 more managers in the register
22 managers hold 80% of the $232.7M institutional base. The other 92 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
ZNTL (Zentalis Pharmaceuticals, Inc.) has 5 disclosed suppliers and 1 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
via Squadron Capital Management LLC, Acadian Asset Management LLC, GSA Capital Partners LLP +1 more · 8.60% of ZNTL, 27.18% of LPCN
via Squadron Capital Management LLC, Orbimed Advisors LLC, Marshall Wace LLP +6 more · 8.60% of ZNTL, 7.32% of RLMD
via Acadian Asset Management LLC, Connor, Clark & Lunn Investment Management Ltd., Marshall Wace LLP +3 more · 5.59% of ZNTL, 5.30% of AMPY
via Acadian Asset Management LLC, Connor, Clark & Lunn Investment Management Ltd., Marshall Wace LLP +3 more · 5.59% of ZNTL, 5.43% of ASYS
via Squadron Capital Management LLC, ADAR1 Capital Management, LLC · 8.60% of ZNTL, 12.05% of INM
via 5AM Venture Management, LLC, Acadian Asset Management LLC, GSA Capital Partners LLP · 8.23% of ZNTL, 13.94% of TRDA
Managers holding a meaningful stake in ZNTL also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.